Atea Pharmaceuticals

Price & Volume

Stats

Open	$2.91
Previous Close	$2.91
Day Range	$2.89-$2.95
52W Range	$2.45-$4.02
Market Cap	$230.1M
Shares Short	6M

Financials

Revenue (12 Mos)	$192.1M
Revenue Growth (YoY)	295.2%
Gross Profit (12 Mos)	-$77.1M
Diluted EPS	-$1.62

News

Yahoo Finance • 2 months ago

Atea Pharmaceuticals Q2 2025 slides: HCV program advances with Phase 3 trials underway

Yahoo Finance • 2 months ago

Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Yahoo Finance • 2 months ago

Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025

Yahoo Finance • 3 months ago

Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America

About

CEO	Dr. Jean-Pierre Sommadossi Ph.D.
CFO	Ms. Andrea J. Corcoran J.D.
Address	225 Franklin Street, Boston, MA, United States, 02110
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	56